http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100926975-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-56 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 |
| filingDate | 2007-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100926975-B1 |
| titleOfInvention | Differentiation of Mesenchymal Stem Cells and Culture of Chondrocytes Using Alginate Coated Fibrin / HA Mixture Scaffolds |
| abstract | The present invention relates to a method for differentiation of mesenchymal stem cells using fibrin / HA (hyaluronate) mixture with enhanced in vivo compatibility and durability, a method for culturing chondrocytes, and a therapeutic composition containing the fibrin / HA (hyaluronate) mixture. More specifically, a method of culturing chondrocytes using an alginate-coated fibrin / HA (hyaluronate) gel and a method of differentiating chondrocytes from mesenchymal stem cells and a fibrin / HA (hyaluronate) mixture containing a fibrin degradation inhibitor It relates to a composition for treating cartilage disease and a composition for treating discs using a support.n n n According to the present invention, the conventional fibrin / HA mixture can be cultured in a more stable environment by overcoming the disadvantage that the size was reduced in size and easily degraded during the culturing, the therapeutic composition according to the present invention is excellent biocompatibility And biodegradability can effectively treat cartilage disease, and unlike the surgical surgical treatment of degenerative intervertebral discs currently used, it is possible to regenerate the new intervertebral disc nucleus, it is expected that the fundamental treatment of the disc.n n n n Fibrin, hyaluronate, mesenchymal stem cells, chondrocytes, differentiation, scaffolds |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101186227-B1 |
| priorityDate | 2007-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.